Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12076 - 12100 of 12704 in total
Experimental
Matched Iupac: … (1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-one …
Experimental
Matched Iupac: … (2S,3S)-2-amino-3-hydroxy-4-(phosphonooxy)butanoic acid …
Experimental
Matched Iupac: … (2S)-3-{[(2S)-2,3-dihydroxypropyl phosphonato]oxy}-2-hydroxypropyl hexadecanoate …
Experimental
Matched Iupac: … 2-[(2R)-2-{[(benzyloxy)carbonyl]amino}-3-sulfanylpropanamido]acetic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-{[(4-bromophenyl)methyl]sulfanyl}propanoic acid …
Experimental
Matched Iupac: … aluminium(3+) ion bis(2-(4-chlorophenoxy)-2-methylpropanoate) hydroxide …
Experimental
Matched Iupac: … 1-(2-{1-ferra-1,1'-spirobi[pentacyclo[2.2.0.0^{1,3}.0^{1,5}.0^{2,6}]hexane]-2-yl}ethyl)-2,5-dihydro-1H-pyrrole …
Experimental
Matched Iupac: … -1-yl]acetic acid ... 2-[(4Z)-2-[(1R,2R)-1-amino-2-hydroxypropyl]-4-[(4-hydroxyphenyl)methylidene]-5-oxo-4,5-dihydro-1H-imidazol …
Antroquinonol has been used in trials studying the treatment of Hyperlipidemias, Non-small Cell Lung Cancer, and Non-small Cell Lung Cancer Stage IV.
Investigational
Matched Iupac: … -2-en-1-one ... (4R,5R,6R)-4-hydroxy-2,3-dimethoxy-6-methyl-5-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]cyclohex …
PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999).
Investigational
Matched Iupac: … 2-{4-[4-(azetidin-1-yl)-7-methylimidazo[4,3-f][1,2,4]triazin-5-yl]-1-methyl-1H-pyrazol-5-yl}-5-(trifluoromethyl …
Ningetinib is under investigation in clinical trial NCT03758287 (Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative).
Investigational
Matched Iupac: … N-(3-fluoro-4-{[7-(2-hydroxy-2-methylpropoxy)quinolin-4-yl]oxy}phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3 …
Evacetrapib has been used in trials studying the basic science and treatment of Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Hepatic Insufficiency, and Cardiovascular Disease.
Investigational
Matched Iupac: … benzazepin-1-yl]methyl}cyclohexane-1-carboxylic acid ... trifluoromethyl)phenyl]methyl}(2-methyl-2H-1,2,3,4-tetrazol-5-yl)amino)-7,9-dimethyl-2,3,4,5-tetrahydro-1H-1- …
Aprindine is a cardiac depressant used in arrhythmias.
Experimental
Matched Iupac: … N-[3-(diethylamino)propyl]-N-phenyl-2,3-dihydro-1H-inden-2-amine …
Experimental
Illicit
Matched Iupac: … [4,4-bis(thiophen-2-yl)but-3-en-2-yl](ethyl)methylamine …
Experimental
Matched Iupac: … (2S)-2-amino-3-{[hydroxy(propan-2-yloxy)phosphoryl]oxy}propanoic acid …
Experimental
Matched Iupac: … (2S)-2-[(2S)-3-phenyl-2-[(2S)-2-sulfanylheptanamido]propanamido]propanoic acid …
Experimental
Matched Iupac: … 2-{[1,1'-biphenyl]-4-yl}-6-fluoro-3-methylquinoline-4-carboxylic acid …
Experimental
Matched Iupac: … (2S,3R,4S,5S,6R)-3-fluoro-6-(hydroxymethyl)oxane-2,4,5-triol …
Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer).
Investigational
Matched Iupac: … 3-[(1s,4r)-4-(4-chlorobenzenesulfonyl)-4-(2,5-difluorophenyl)cyclohexyl]propanoic acid …
Trofosfamide has been used in trials studying the treatment of Ependymomas, Medulloblastomas, Sarcoma, Soft Tissue, Supratentorial PNETs, and Recurrent Brain Tumors.
Investigational
Matched Iupac: … 2-[bis(2-chloroethyl)amino]-3-(2-chloroethyl)-1,3,2lambda5-oxazaphosphinan-2-one …
Experimental
Matched Iupac: … 2-[(2-hydroxyethyl)disulfanyl]ethan-1-ol …
Experimental
Matched Iupac: … N-(prop-2-en-1-yl)aniline …
Experimental
Matched Iupac: … (10E,12Z)-hexadeca-10,12-dien-1-ol …
Cloridarol is an experimental medication in the treatment of heart disease, which acts through vasodilation. It was studied for the treatment of coronary insufficiency in Italy in the 1970s .
Experimental
Matched Iupac: … (1-benzofuran-2-yl)(4-chlorophenyl)methanol …
Displaying drugs 12076 - 12100 of 12704 in total